Pain - pain management

Comprehensive Study Guide: Pain and Pain Management

This study guide provides a clinically rigorous overview of pain management based on the provided nursing curriculum materials. It covers the definitions, physiology, assessment, and multidimensional treatment of pain.

Module 1: Definitions, Nature, and Scope of Pain

Definitions of Pain

    •    McCaffery’s Definition (1968): Pain is "whatever the experiencing person says it is, existing whenever he says it does." This establishes the patient’s report as the most reliable indicator of pain.

    •    IASP Revised Definition (2021): "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage."

    ◦    Key Notes: Pain is always a personal experience influenced by biological, psychological, and social factors. Pain and nociception are distinct phenomena; pain cannot be inferred solely from sensory neuron activity.

Nature and Scope

    •    Nature of Pain: Pain serves as a protective mechanism (e.g., withdrawing a hand from heat) but can become pathologic when it persists past normal healing time. It is a motor, sensory, and emotional response.

    •    Scope Continuum:

    ◦    Intensity: Ranges from none to minimal, moderate, and severe.

    ◦    Frequency: Intermittent to constant.

    ◦    Duration: Acute vs. Chronic.

    ◦    Location: Well-localized to widespread.

Acute vs. Chronic Parameters

Feature

Acute Pain

Chronic (Persistent) Pain

Onset

Sudden; linked to a specific event/injury.

Gradual or persisting after injury.

Duration

Less than 3 to 6 months; dissipates with healing.

Longer than 3 months (post-op) or 6 months.

Purpose

Protective; alerts to harm.

Serves no useful purpose; pathologic.

Physiologic Response

Sympathetic (↑ HR, ↑ BP).

Parasympathetic (potential ↓ BP, ↓ HR).

Module 2: Physiology of Pain and Nociception

The Four Physiological Steps (Nociception)

    1    Transduction: Nociceptors detect noxious stimuli (thermal, mechanical, chemical) and convert this into an electrical impulse. Tissue injury releases chemical mediators (prostaglandins, bradykinin, serotonin, substance P, histamine) that activate nociceptors.

    2    Transmission: The action potential travels along afferent nerve fibers to the spinal cord and brain.

    ◦    A-delta fibers: Large-diameter, myelinated, rapid conduction. Translate as sharp, acute pain.

    ◦    C fibers: Smaller, unmyelinated, slow conduction. Translate as diffuse, dull, aching pain.

    ◦    Spinothalamic Tract: The primary route for pain signals to the brain.

    3    Perception: The brain translates signals into the experience of pain. The thalamus sends impulses to the somatosensory cortex (location/intensity), limbic system (emotional reaction), and frontal cortex (thought/reason).

    4    Modulation: The brain sends inhibitory input to the spinal cord to impede transmission. This triggers the release of endogenous opioids:

    ◦    Enkephalins: Influence perception and emotional aspects.

    ◦    Beta-endorphins: Reduce pain in central and peripheral systems.

    ◦    Dynorphins: Modulators that can stimulate or reduce pain.

Pain Theories

    •    Specificity Theory: Identifies specific nerve endings for touch, cold, heat, and pain.

    •    Sensory Interaction Theory: Large-diameter fibers (touch) can inhibit signals from thin fibers (pain).

    •    Gate Control Theory: A "gating mechanism" in the dorsal horn of the spinal cord determines if impulses reach the brain. Non-painful stimuli (massage, TENS) can "close the gate" by stimulating different fibers.

    •    Neuromatrix Theory: Pain is a multidimensional experience produced by a genetically controlled network of neurons (body-self neuromatrix), unique to each person and modified by experience.

Module 3: Classifications and Types of Pain

Nociceptive Pain

Physiologic pain resulting from nociceptor stimulation.

    •    Somatic: Results from injury to skin, muscles, bones, and joints (e.g., fractures, arthritis). Usually sharp and well-localized.

    •    Visceral: Arises from internal organs (e.g., appendicitis, bladder distention). Responds to stretching and swelling; may be crampy or aching.

Neuropathic Pain

Pathologic pain resulting from nerve injury; persists after stimuli are gone.

    •    Sensory Alterations:

    ◦    Dysesthesia: Unpleasant abnormal sensation.

    ◦    Allodynia: Pain from non-injury stimuli (e.g., light touch).

    ◦    Hyperalgesia: Excessive sensitivity to pain.

    ◦    Hyperpathia: Exaggerated pain reaction.

    •    Phantom Limb Pain: Pain in an amputated part; involves plasticity where the brain adapts to the loss.

Other Classifications

    •    Psychogenic Pain: Perceived pain with no identifiable physical cause.

    •    Referred Pain: Originates in one area but is felt in another (e.g., jaw pain during a myocardial infarction).

    •    Radiating Pain: Extends from the source to adjacent areas (e.g., GERD radiating up the esophagus).

    •    Breakthrough Pain: Spikes in pain when chronic pain is otherwise stable.

    ◦    Incident: Precipitated by action/movement.

    ◦    Idiopathic: No known cause.

    ◦    End-of-dose failure: Occurs before the next scheduled analgesic dose.

Module 4: Body System Alterations and Diversity Factors

Physiologic Stress Responses to Pain

    •    Endocrine: Release of cortisol, ACTH, ADH, catecholamines; decrease in insulin. Result: Hyperglycemia and catabolism.

    •    Cardiovascular: ↑ HR, ↑ BP, ↑ oxygen demand. Risk of hypercoagulation, MI, and stroke.

    •    Respiratory: ↑ RR, ↓ tidal volume. Risk of pneumonia and atelectasis.

    •    GI/GU: ↓ motility (constipation), ↓ gastric emptying, ↓ urine output (urinary retention).

    •    Musculoskeletal: Muscle spasms, tension, and fatigue.

    •    Immune: Release of inflammatory mediators; unrelieved pain can suppress immune function.

Diversity and Life Span Factors

    •    Infants/Neonates: Have measurable reactions to pain. Pain can have lasting negative effects on brain development. Use NIPS scale for those <1 year.

    •    Older Adults: High prevalence of chronic pain; not a normal part of aging. Risks include polypharmacy, decreased drug metabolism (leading to toxic levels), and reluctance to report pain.

    •    Gender: Women often have lower thresholds and tolerance. Testosterone may decrease pain perception.

    •    Culture: Influences expression and acceptable treatments.

    •    Morphology: Obese patients are at higher risk for respiratory depression with opioids and may experience more pain due to inflammatory mediators in adipose tissue.

Module 5: Pain Assessment and Diagnostic Tools

Assessment Mnemonics

    •    SOCRATES: Site, Onset, Character, Radiation, Associations, Time course, Exacerbating/Relieving factors, Severity.

    •    PQRST: Provocation, Quality, Region, Severity, Temporality.

    •    OLDCARTS: Onset, Location, Duration, Character, Aggravating factors, Relieving factors, Timing, Severity.

Pain Scales

    •    Numeric Rating Scale (NRS): 0–10 (1–3 mild, 4–7 moderate, 8–10 severe).

    •    Wong-Baker FACES: Six cartoon faces (0–10). Used for adults and children as young as 3.

    •    Faces Pain Scale-Revised (FPS-R): Six neutral-to-painful faces (0, 2, 4, 6, 8, 10).

    •    Neonatal Infant Pain Scale (NIPS): Uses facial expression, cry, breathing, arms, legs, and arousal. Score >3 indicates pain.

Hierarchy of Importance (Nonverbal/Cognitively Impaired)

    1    Attempt self-report.

    2    Consider underlying pathology/procedures.

    3    Observe behaviors (grimacing, restlessness).

    4    Evaluate physiologic indicators (vital signs).

    5    Conduct an analgesic trial.

Monitoring

    •    Sedation Monitoring: The most sensitive indicator of impending respiratory depression.

    •    Vital Signs: ↑ HR/BP in acute pain; potential ↓ HR/BP in chronic/prolonged pain.

Module 6: Nursing Diagnoses, Goals, and Care Planning

Nursing Diagnoses (ICNP)

    •    Acute Pain: Linked to tissue injury (e.g., burns, surgery).

    •    Chronic Pain: Linked to long-term conditions (e.g., arthritis).

    •    Difficulty Coping: Linked to severe pain and feelings of helplessness.

Planning and Goals

    •    Prioritization: Use Maslow’s hierarchy (physical needs first).

    •    Outcome Criteria: Must be realistic and measurable (e.g., "Patient will report pain level of 3/10 within 1 hour of medication").

    •    Delegation: Nurses can delegate nonpharmacologic tasks to UAP, such as:

    ◦    Administering back rubs.

    ◦    Repositioning for comfort.

    ◦    Oral hygiene and changing linens.

    ◦    Darkening the room/reducing stimuli.

Module 7: Pharmacologic Pain Management

Nonopioids

    •    Acetaminophen: Analgesic and antipyretic. Hepatotoxicity risk; total daily dose should not exceed 3000 mg.

    •    NSAIDs (Ibuprofen, Aspirin): Anti-inflammatory. Side effects: GI bleeding, renal complications, and cardiac risks. Aspirin decreases platelet aggregation.

Opioids

    •    Agonists: Morphine, Fentanyl, Hydromorphone. For severe pain (7–10). Side effects: Respiratory depression, constipation, nausea, itching, urinary retention.

    •    Agonist-Antagonists: Nalbuphine, Butorphanol. For moderate to severe pain; depresses impulses at the spinal cord.

    •    Antagonist (Naloxone): Reverses opioid overdose. Administer 0.4–2 mg every 2–3 minutes if RR <10.

Patient-Controlled Analgesia (PCA)

    •    Electronically controlled infusion.

    •    Lockout time: Prescribed interval between doses to prevent overdose.

    •    PCA by Proxy: Unauthorized activation by anyone other than the patient (family members must not push the button).

    •    Monitoring: Requires two-nurse verification of settings.

WHO Analgesic Ladder

    1    Step 1 (Mild): Nonopioid ± Adjuvant.

    2    Step 2 (Moderate): Weak opioid + Nonopioid ± Adjuvant.

    3    Step 3 (Severe): Strong opioid + Nonopioid ± Adjuvant.

Key Concepts

    •    Multimodal Analgesia: Using more than one means of control (e.g., Acetaminophen + Morphine) to lower doses and reduce side effects.

    •    Preemptive Analgesia: Administered before a painful event (e.g., before dressing changes).

    •    Tolerance: Adaptation leading to less effective relief.

    •    Physical Dependence: Withdrawal symptoms upon cessation.

    •    Addiction/Substance Use Disorder: Psychological craving and compulsive use regardless of consequences.

Module 8: Nonpharmacologic, Invasive, and Alternative Therapies

Physical and Mind-Body Therapies

    •    Thermal Measures: Heat (vasodilation) or Cold (vasoconstriction). Apply for 15 minutes only to avoid tissue injury.

    •    Massage: Promotes relaxation and decreases muscle tension.

    •    TENS: Low-intensity current via skin electrodes. Contraindicated for pacemakers or arrhythmias.

    •    Mind-Body: Guided imagery, meditation, biofeedback, music therapy.

Invasive and Surgical Procedures

    •    Spinal Cord Stimulation (SCS): Implanted device in the epidural space.

    •    Nerve Block: Injection of local anesthetic near nerves.

    •    Cordotomy: Disabling pain-conducting tracts in the spinal cord.

    •    Rhizotomy: Severing nerve roots in the spinal cord.

    •    Neurectomy: Surgical removal of a nerve.

Safety and Specialized Care

    •    Home Safety: "Up and Away" initiative for securing medications to prevent accidental ingestion by children. Never call medication "candy."

    •    Palliative Care: Goal is to relieve pain/suffering from serious illness regardless of prognosis.

    •    Medical Marijuana: Used for neuropathic pain and spasms; not FDA approved. Short-term effects include memory/learning impairment.